Skip to search formSkip to main contentSkip to account menu

BRENTUXIMAB

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Epstein-Barr virus (EBV) is a ubiquitous herpes virus that infects the majority of the population worldwide. The virus can… 
2019
2019
CD19-specific CAR-T cells are highly successful against B-cell non-Hodgkin lymphomas and acute lymphoblastic leukemia but… 
Review
2018
Review
2018
Hodgkin lymphoma (HL) is a unique hematopoietic neoplasm characterized by cancerous Reed‐Sternberg cells in an inflammatory… 
Highly Cited
2017
Highly Cited
2017
BACKGROUND Targeting CD30 with monoclonal antibodies in Hodgkin lymphoma (HL) and anaplastic large cell lymphoma (ALCL) has had… 
2017
2017
Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic… 
2016
2016
Rapid identification of cytokine release syndrome after haploidentical PBSC transplantation and successful therapy with… 
2016
2016
Acute pulmonary toxicity associated with brentuximab appears to be a rare but serious adverse effect that can be potentially… 
2016
2016
Monoclonal antibody therapy is a new innovation in cancer therapy. Binding of monoclonal antibodies to tumor cells facilitates… 
2015
2015
Among haematological malignancies, Hodgkin’s lymphoma (HL) remains a disease with a high cure rate and overall survival rate of…